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Summary
Paired lines of C3H mouse fibroblasts transformed with murine sarcoma virus (Kirsten strain)
were prepared that express high or low levels ofclass II major histocompatibility complex antigen
after treatment with interferon y (IFN-y). Here, we described a comparison of the tumorigenicity
of these lines in euthymic syngeneic and thymus-deficient nu/nu mice and in mice depleted of
IFN-y. The class II-inducible cells are clearly less tumorigenic than the noninducible cells in
syngeneic mice, but of similar tumorigenicity in nu/nu mice and in mice treated with antibodies
to deplete IFN-y . We propose that in this system, IFN-y induction of class II antigens on the
tumor cell surface operates to limit tumor growth; ras expression, which inhibits induction of
class II antigens, prevents this and so allows tumor growth.
C
ells experimentally transformed or infected with viruses,
and also some naturally occurring tumor cells, may ex-
press reduced levels of antigens of the MHC compared with
"normal" cells (1-3). Since MHC antigens are essential for
T cell activation, reduced expression by tumor cells could
lead to theirescaping immunological attack, even where there
are potentially immunogenic neoantigens present. There have
been several studies that have shown that increased class I
expression may reduce tumorigenicity (4, 5), but little evi-
dence of a role for class II antigens in control of tumorige-
nicity. However, in one experimental system, transfection of
class II genes into murine tumor cells resulted in reduced
tumorigenicity (6), and there have been several reports that
the (class II-restricted) CD4 subset of T cells is important
in the rejection of tumors in unprimed animals (7-9). The
IFNs increase the expression ofclass I MHC antigens on many
cell types (10); IFN-y alone will additionally induce class 11
MHC antigen (11, 12) . IFN induction of MHC class I ex-
pression in virus-infected cells or tumor cells can increase their
susceptibility to killing by virus-specific CD8 (cytotoxic) T
cells in vitro (13, 14). Similarly, IFN-y induction of class
II antigens may increase CD4 T cell-mediated responses (15).
We have previously reported (12) that when a line ofC3H
mouse fibroblasts (C3H 1OTl/2) is transformed by the v-Ki-
ras oncogene, elevation of class I antigens after IFN-y treat-
ment is unaffected, but the induction by IFN-y of class II
antigens is largely abolished. There remained in these trans-
formed lines a small subpopulation of cells still inducible for
class II antigen. This enabled the production of sublines (by
fluorescence-activated cell sorting [FRCS is a registered trade-
mark ofBecton Dickinson & Co.]) retaining the classII MHC
induction shown by the parental C3H 10T1/2 line (16) . We
report here that these class II-inducible cells, when compared
with the class II-noninducible cells, are less tumorigenic in
syngeneic euthymic hosts but are of similar tumorigenicity
in thymusless nu/nu mice or mice treated with mAb to de-
plete IFN-y. Both cell lines show similar in vitro properties.
We conclude that in this system one mechanism controlling
tumor growth may involve expression of class II antigens by
the tumor cells. A high proportion of naturally occurring
human tumors exhibit ras gene activation (17-19); ifthe abro-
gation ofinduction ofMHC classII antigen gene expression
by ras occurs in human tumors, this may play a role in the
development of tumors and their escape from immune rec-
ognition.
Materials and Methods
Cell Lines.
￿
The C3H IOTI/2 fibroblastline was obtained from
the American Type Culture Collection(Rockville, MD). The C3H
201 cell line (12) was derived from C3H IOTI/2 by infection with
a helper virus-free preparation of the Kirsten strain of murine sar-
coma virus (MSV)' prepared by transfection of the 0-2 helper cell
' Abbreviation used in this paper . MSV, murine sarcoma virus.
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of the transformed cellswere prepared as previously described(16)
by several cycles of IFN-'y treatment, staining for class II antigens,
andsorting low andhigh expressing cells. Lines so obtained were
designated 369L and369R, respectively (L indicates left sorted and
R indicates right sorted). These lines were maintained in MEM
(Gibco Laboratories, Paisley, Scotland) supplemented with 10% FCS
(Flow Laboratories, Irvine, Scotland) at 37°C in a 95% air 5%
C02 atmosphere.
Animalsand TumorAssays.
￿
6-8-wk-old C3H/He mice from our
own animal facility were injected subcutaneously with graded doses
ofcellsin avolume of0.1 ml ofculture medium; MR nu/numice.
obtained from OLAC Ltd., Bicester, England, were similarly in-
jected with 300cells. Tumors, whichusually appearedwithin 7-14 d
in euthymic mice and 21-35 din nu/nu mice, were scored visually
and by palpation.
In Vivo Depletion o .fIFN-y with mAh
￿
The rat mAb R4-6A2
(22) waspurified from ascitic fluidusing protein A-Sepharose (Phar-
macia Ltd., Milton Keynes, UK) in high salt buffer. C3H/He fe-
male mice (6-8 wk old) were injected intravenously with antibody
1 wk before inoculation subcutaneously with 369R or 369L cells,
and then givenantibody intraperitoneally every 7duntiltermina-
tion oftheexperiment. In initial experiments, theamount of mAb
given per injection varied from 0 to 200 hg. All amounts >3 jig
were foundto be equally effective in increasing tumor growth,and
astandard dose of30 ftgper injection was subsequently used.Con-
trol mice received an equivalent amount of rat immunoglobulin
(Sigma Chemical Co., Poole, UK) or no injection. Therewas no
difference observed between these two control groups.
Results and Discussion
Characteristics ofSorted Lines.
￿
The MHC phenotypes of
the sorted lines aredescribedelsewhere(16). In brief, neither
of thelines expressesclass II antigenin theabsence of IFN-y,
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Figure 1.
￿
IFN-.y-induced H-2 Kk and I-Ak expression on 369L and
-R cells. IFN-.y-treated cells were stained with mouse mAbs to H-2 Kk
(TIB 95/11.4.1) or H-2 Ak (TIB92) under saturating conditions as de-
scribedin detail elsewhere (12). FITC goat anti-mouseIg (CappelLabora-
tories, Malvern, PA) wasused as the second layer. Stained cellswere ana-
lyzed on a FACStarflow cytometer(Becton Dickinson & Co., Mountain
View, CA). (Solid line) I-Ak, 369L; (spaced dots) I-Ak, 369R; (close dots)
H-2 Kk, 369L; (dashed line) H-2Kk, 369R.
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Tumorigenicity Correlates with Low Class 11 Inducibility
cell inoculum (105)
Figure 2.
￿
Tumorigenicity of369L and-R in syngeneic euthymic mice.
Graded numbersofcellswere inoculated into C3H/He mice,andtheper-
centage of mice developing tumors wasrecorded. Hatched bars indicate
369L and open bars indicate 369R. Numbers in parentheses indicate the
total number of mice inoculated.
but after treatment with IFN-y, the right sorted line 369R
expresses about the same as do IFN-y-induced normal C3H
1OT1/2 fibroblasts; theleft sorted line 369L is weakly induc-
ible for class II. C3H10T1/2 and 369L or -R express little
class I antigen in the absence of IFN-y, although all lines
expressvery largeamounts ofclassI antigenafterIFN-ytreat-
ment (see Fig. 1).
Tumorigenicity in Immunocompetent SyngeneicMice.
￿
As Fig.
2 indicates, theleft sorted cells were more tumorigenic than
the right sorted cells in C3H/He mice. These results were
highly significant by X2 test. Tumors developing in mice in-
oculated with right sorted cells also grew more slowly. The
data shown in Fig. 2 were pooled from several experiments
carried out at different in vitro passage levels after sorting.
There was no dependence of tumorigenicity on the number
of passages after sorting; this is consistent with the finding
that the MHC phenotype is relatively stable (16).
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Figure 3.
￿
Tumorigenicity of 369L and -R in athymic nu/nu mice.
Thresholdnumbers of cellswere inoculated into nude mice, and the per-
centage of mice developing tumors was recorded as a function of time.
Open circles indicate 369L and closed circles indicate 369R. There was
a total number of 20 mice per group.Table 1.
￿
Effect of R4-6A2 Antibody on the Growth of 369L
and -R Cells in Mice
Percent tumors (no. of mice) in
mice inoculated with :
369L
￿
369R
R4-6A2 R4-6A2
The data are pooled from several experiments. In some, control animals
were left untreated, in others, control animals were treated with rat Ig
(R4-6A2 is a rat antibody); this made no difference to tumor growth.
Tumorigenicity in Thymus-deficient nulnu Mice.
￿
Of partic-
ular interest is the tumorigenicity of the cells in T cell--deficient
mice, since one interpretation of our data is that T cells in-
teracting with the induced class II antigens may be limiting
growth in vivo of the cells. Both cell lines were markedly
more tumorigenic in nulnu mice, but at threshold inocula,
it was clear that there was no significant difference (by Xa
test) between the growth ofclass II-inducible cells and their
noninducible partners (Fig. 3).
Effects on Tumorigenicity ofSorted Cell Lines of Treatment of
EuthymicMice with Antibody to IFN-y. Treatment ofC3H/He
mice with the mAb R4-6A2 resulted in an increased tumor
incidence in mice inoculated either with 369R or 369L cells
(Table 1). The tumorigenicity ofequal numbers of 369L and
-R cells was directly compared in antibody-treated mice (Fig.
4). It was found that under these conditions, there was no
significant difference between the two lines (by XZ test).
That is to say the lower tumorigenicity of class 11-inducible
369R cells normally seen in euthymic mice was abolished
in mice treated with anti-IFN-y immunoglobulin.
Lack of Correlation with Tumorigenicity of Other Properties
ofthe Sorted Cell Lines. We have extensively studied these
lines in an attempt to determine whether any otherproperty
of the cells that may influence tumorigenicity in euthymic
mice correlates with the inducibility of class II antigen. We
have previously reported that the amounts of ras gene product
(mRNA and p21 protein product) and the IFN sensitivities
are the same (16). Here, we additionally report that growth
rate in vitro, anchorage dependence, sensitivity to TNF (with
or without IFN-y), and NK cytotoxicity are essentially the
same in the left and right sorted lines (data not shown).
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Figure 4.
￿
Tumorigenicity of 369L and -R in syngeneic mice treated
with antibody to IFN-y. Graded numbersof369L and-R cells were inoc-
ulated into CM/He mice treated with R4-6A2 antibody, and the per-
centage of mice developing tumors was recorded as a function of time.
Open symbols indicate 369L andclosed symbols indicate 369R,with high
andlowinducibility ofclass II antigens, respectively. (Circles) 100,000cells;
(triangles) 10,000 cells; 10 mice per group.
The finding that the left and right sorted lines are equally
tumorigenic in nude mice, and in fact markedly more tumori-
genic than in euthymic mice, implies a role for T cells in
resistance to the growth of these cells in vivo; and the con-
clusion that it is CD4 phenotype T cells interacting via IFN-
y-induced class 11 antigens in the right sorted cells that de-
termines their decreased tumorigenicity is attractive.
IFN-y may have multiple effects on tumor cell growth
in vivo; either directly, or by interaction with other compo-
nents of the immune response. The observation that both
369R and 369L cellsproduced tumors more readily in IFN-
y-depleted mice may reflect these multiple effects of IFN.
However, the finding (Fig. 4) that IFN-T abolished the differ-
ence in tumorigenicity between these lines implies that the
induction of class II antigens on the cells themselves plays
a role in control of tumor growth. IFN-y-induced class I
antigens are unlikely to be important in this situation since
369R and 369L show similar levels of class I antigens after
IFN treatment.
An additional pair of v-Ki-ras-transformed cell linesindepen-
dently derived from C3H10T1/2 by infection with the Ki-
MSV/MLV (16) gave results equivalent to those reported here
for 369L and -R.
Our results stress the importance of examining not only
constitutive expression of MHC antigens on cell surfaces when
considering mechanisms controlling tumor growth, but also
the possible modulation or induction of such antigens that
may occur in vivo. Here, our observation that ras expression
can abrogate class II induction (12) is particularly relevant
since this, with the present results, implies a mechanism by
which such ras-induced tumors may escape T cell-mediated
tumor surveillance.
Cells per mouse
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100,000
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ND
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ND
ND
treated
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100 (10)
Control
33 (45)
50 (10)
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